Our vision for HUPO2017 Congress on “Integrated Proteomics for Healthcare Systems” is to create a meeting that will bring together world leaders with a new generation of scientists to promote HUPO’s capabilities for advancing our knowledge of the Human Proteome and the impact this will have on our understanding of health, disease and ageing. The Congress will celebrate past achievements and present new disruptive advances in proteomics. This will be achieved by a balanced scientific programme that takes into account previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities.
The programme will include key outreach events as well as sessions devoted to each of the twelve (12) current HUPO Initiatives and to the three (3) pillars of the HPP.
In recognition of the increasing role of proteomics in medicine development and point of care testing, and the consequential impact on the biopharmaceutical industry, we will have a special focus on the application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.